journal article·2023-08-16

Nanoanalytical Insights into the Stability, Intracellular Fate, and Biotransformation of Metal–Organic Frameworks

Anna Lena Neuer, Deborah Geck, Alexander Gogos, Vera M. Kissling, Alice Balfourier, Inge K. Herrmann

ACS Applied Materials & Interfaces· Volume 15· Issue 32
Publisher page

Abstract

Metal-organic frameworks (MOFs) have found increasing applications in the biomedical field due to their unique properties and high modularity. Although the limited stability of MOFs in biological environments is increasingly recognized, analytical techniques have not yet been harnessed to their full potential to assess the biological fate of MOFs. Here, we investigate the environment-dependent biochemical transformations of widely researched nanosized MOFs (nMOFs) under conditions relevant to their medical application. We assess the chemical stability of antimicrobial zinc-based drug delivery nMOFs (Zn-ZIF-8 and Zn-ZIF-8:Ce) and radio-enhancer candidate nMOFs (Hf-DBA, Ti-MIL-125, and TiZr-PCN-415) containing biologically nonessential group IV metal ions. We reveal that even a moderate decrease in pH to values encountered in lysosomes (pH 4.5-5) leads to significant dissolution of ZIF-8 and partial dissolution of Ti-MIL-125, whereas no substantial dissolution was observed for TiZr-PCN-415 and Hf-DBA nMOFs. Exposure to phosphate-rich buffers led to phosphate incorporation in all nMOFs, resulting in amorphization and morphological changes. Interestingly, long-term cell culture studies revealed that nMOF (bio)transformations of, e.g., Ti-MIL-125 were cellular compartment-dependent and that the phosphate content in the nMOF varied significantly between nMOFs localized in lysosomes and those in the cytoplasm. These results illustrate the delicate nature and environment-dependent properties of nMOFs across all stages of their life cycle, including storage, formulation, and application, and the need for in-depth analyses of biotransformations for an improved understanding of structure-function relationships. The findings encourage the considerate choice of suspension buffers for MOFs because these media may lead to significant material alterations prior to application.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory for Particles-Biology Interactions, Department of Materials Meet Life, Swiss Federal Laboratories for Materials Science and Technology (Empa), Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland

Nanoparticle Systems Engineering Laboratory, Institute of Process Engineering, Department of Mechanical and Process Engineering, ETH Zurich, Sonneggstrasse 3, 8092 Zurich, Switzerland

Laboratoire des BioMolécules (LBM), Département de Chimie, Sorbonne Université, École Normale Supérieure, PSL University, CNRS, 75005 Paris, France

Funding

Eidgenössische Technische Hochschule Zürich · Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · Swiss Cancer Research Foundation · Gebauer Stiftung · OPO-Stiftung

References (54)

Show source-provided references
1. 10.1002/adfm.20170513710.1002/adfm.201705137 ↗
2. 10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
3. 10.1038/s41467-018-04703-w10.1038/s41467-018-04703-w ↗
4. 10.1039/D2BM00973K10.1039/D2BM00973K ↗
5. 10.1039/C9SC00747D10.1039/C9SC00747D ↗
6. 10.1021/jacs.9b0302910.1021/jacs.9b03029 ↗
7. 10.1016/j.ccr.2017.08.01510.1016/j.ccr.2017.08.015 ↗
8. 10.1021/ar200028a10.1021/ar200028a ↗
9. 10.1002/adhm.20180002210.1002/adhm.201800022 ↗
10. 10.1016/B978-0-12-816984-1.00020-210.1016/B978-0-12-816984-1.00020-2 ↗
11. 10.1016/j.ccr.2019.21302210.1016/j.ccr.2019.213022 ↗
12. 10.1002/chem.20140538010.1002/chem.201405380 ↗
13. 10.1021/la501255510.1021/la5012555 ↗
14. 10.1039/D2TB00459C10.1039/D2TB00459C ↗
15. 10.1039/C7DT04116K10.1039/C7DT04116K ↗
16. 10.1021/acs.chemmater.7b0132910.1021/acs.chemmater.7b01329 ↗
17. 10.1016/j.chempr.2017.02.00510.1016/j.chempr.2017.02.005 ↗
18. 10.1080/17435390.2017.127936110.1080/17435390.2017.1279361 ↗
19. 10.2217/nnm.15.15210.2217/nnm.15.152 ↗
20. 10.1039/C9CE00757A10.1039/C9CE00757A ↗
21. 10.1016/j.ijpharm.2016.08.01010.1016/j.ijpharm.2016.08.010 ↗
22. 10.1039/c1dt10115c10.1039/c1dt10115c ↗
23. 10.3390/nano710032110.3390/nano7100321 ↗
24. 10.1002/adbi.20230007510.1002/adbi.202300075 ↗
25. 10.1021/ja809459e10.1021/ja809459e ↗
26. 10.1039/C9TB01743G10.1039/C9TB01743G ↗
27. 10.2147/IJN.S26732110.2147/IJN.S267321 ↗
28. 10.1007/s11705-020-1927-810.1007/s11705-020-1927-8 ↗
29. 10.1021/acscentsci.7b0049710.1021/acscentsci.7b00497 ↗
30. 10.1002/adma.20170450110.1002/adma.201704501 ↗
31. 10.1038/s41467-022-32809-910.1038/s41467-022-32809-9 ↗
32. 10.1073/pnas.191173411610.1073/pnas.1911734116 ↗
33. 10.1039/C9CE00757A10.1039/C9CE00757A ↗
34. 10.1073/pnas.191173411610.1073/pnas.1911734116 ↗
35. 10.1016/j.mtla.2021.10115410.1016/j.mtla.2021.101154 ↗
36. 10.1038/s41598-017-03526-x10.1038/s41598-017-03526-x ↗
37. 10.1021/jacs.6b0196610.1021/jacs.6b01966 ↗
38. 10.2147/IJN.S4977010.2147/IJN.S49770 ↗
39. 10.1073/pnas.75.7.332710.1073/pnas.75.7.3327 ↗
40. 10.1186/s40035-015-0041-110.1186/s40035-015-0041-1 ↗
41. 10.1016/j.addr.2004.05.00310.1016/j.addr.2004.05.003 ↗
42. 10.1016/j.addr.2006.09.02010.1016/j.addr.2006.09.020 ↗
43. 10.1016/j.ccr.2018.03.00610.1016/j.ccr.2018.03.006 ↗
44. 10.1016/j.micromeso.2019.10956810.1016/j.micromeso.2019.109568 ↗
45. 10.1007/s40094-014-0141-910.1007/s40094-014-0141-9 ↗
46. 10.1093/jn/130.5.1374S10.1093/jn/130.5.1374S ↗
47. Roohani N. · J. Res. Med. Sci.: Off. J. Isfahan Univ. Med. Sci. · 2013 · 18 · 144
48. 10.1002/cplu.20140208010.1002/cplu.201402080 ↗
49. 10.1177/019262331773725410.1177/0192623317737254 ↗
50. 10.1039/C6TB03379B10.1039/C6TB03379B ↗
51. 10.1039/c4ee01009d10.1039/c4ee01009d ↗
52. 10.1016/j.colsurfa.2019.02.02510.1016/j.colsurfa.2019.02.025 ↗
53. 10.1038/nmat260810.1038/nmat2608 ↗
54. 10.1039/C8BM00625C10.1039/C8BM00625C ↗